Applied DNA Sciences Inc APDN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APDN is a good fit for your portfolio.
News
-
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
-
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
-
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
-
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
-
Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Trading Information
- Previous Close Price
- $0.43
- Day Range
- $0.41–0.45
- 52-Week Range
- $0.37–1.86
- Bid/Ask
- $0.41 / $0.44
- Market Cap
- $6.96 Mil
- Volume/Avg
- 50,495 / 118,513
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.60
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 55
- Website
- https://www.adnas.com
Valuation
Metric
|
APDN
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.33 |
Price/Sales | 0.60 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
APDN
|
---|---|
Quick Ratio | 1.47 |
Current Ratio | 1.77 |
Interest Coverage | — |
Quick Ratio
APDN
Profitability
Metric
|
APDN
|
---|---|
Return on Assets (Normalized) | −77.13% |
Return on Equity (Normalized) | −170.76% |
Return on Invested Capital (Normalized) | −151.40% |
Return on Assets
APDN
Diagnostics & Research Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Czsfhpklj | Tdnhz | $221.6 Bil | |
DHR
| Danaher Corp | Srkxvytzl | Zdhpm | $184.9 Bil | |
IQV
| IQVIA Holdings Inc | Ldfvkwrct | Qshddwn | $46.0 Bil | |
IDXX
| IDEXX Laboratories Inc | Jsghdshkk | Mdhyvgq | $44.8 Bil | |
A
| Agilent Technologies Inc | Dhcjwprkvp | Znm | $42.6 Bil | |
MTD
| Mettler-Toledo International Inc | Ppjmgzxjx | Ttlfphf | $28.5 Bil | |
ICLR
| Icon PLC | Jyynznv | Lwmhs | $27.7 Bil | |
ILMN
| Illumina Inc | Ljbprhh | Kcvcnjc | $21.8 Bil | |
WAT
| Waters Corp | Wvyghqrssf | Bvj | $20.4 Bil | |
LH
| Laboratory Corp of America Holdings | Ylnnjbzsjb | Hfbsyr | $18.4 Bil |